Publications » Search Results » 2010

 2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962  1961
Show per page  
Conferences
11Liepina I.; Zemitis A.; Duburs G.; Czaplewsky C.; Liwo A. Artifical lipid and its binding with DNA. Abstract Book Cell Penetrating Peptides, 31st European Peptide Symposium CPP satellite meeting ; September 10-11: Copenhagen, 2010.      

12Lapidus D. ; Ventura S.; Czaplewsky C.; Liwo A.; Liepina I. Molecular dynamics of Amyloid single beta-sheet. Tēzes = Abstracts, 8. Latvijas matemātikas konference = 8th Latvian mathemātical conference; April 9-10: Valmiera, Latvia, 2010; 43.      

13Duka V.; Bestel I.; Czaplewsky C.; Liwo A.; Liepina I. Molecular modeling of a single beta-sheet of Amyloid B-protein (Abeta) 25-35. Tēzes = Abstracts, 8. Latvijas matemātikas konference = 8th Latvian mathemātical conference ; April 9-10: Valmiera, Latvia, 2010; 27.      

14Svalbe B.; Muceniece R.; Vavers E.; Liepinsh E.; Zvejniece L. The antihypnotic and anrihypoxic effects of Mildronate. In Focused Conference Group: P14 - Addition and doping: Neurobiological and clinical . Final Programme , WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 1699, 2010; 598.      

15Skapare E.; Liepinsh E.; Svalbe B.; Dambrova M. Cardioprotective drug Mildronate enhances the anti-diabetic activity of metformin in obese zucker rats. In Focused Conference Group: P05 - Translational sience in the metabolic syndrome: basic and clinical pharmacology . Final Programme, WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 674, 2010; 583.      

16Klusa V.; Pupure J.; Isajevs S.; Svirina D.; Beitnere U.; Jansone B.; Rumaks J.; Svirskis S.; Vilskersts R.; Kalvinsh I. Neuroprotective effect of Mildronate, a mitochondria-targeted drug, in Parkinson,s disease model in rats. In Focused Conference Group: PW19 - Influence of degeneration and repair in the CNS and periphery. Final Programme, WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 1746, 2010; 381.      

17Dzirkale Z.; Pupure J.; Rumaks J.; Vanina M.; Svirskis S.; Mezhapuke R.; Fernandes M.A.; Duburs G.; Muceniece R.; Klusa V. Taurine and its analogue tauropyrone: comparative pharmacological activities. In Focused Conference Group: P11-G. Protein-coupled 7TM receptors: from molecular to physiological function . Final Programme, WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 1747, 2010; 263.      

18Svalbe B.; Muceniece R.; Liepinsh E.; Dambrova M.; Zvejniece L. L-Carnitine regulator - mildronate exerts acute anticinvulsant and antihypnotic effects. Abstracts, 35th FEBS Congress Molecules of Life; June 25 - July 1: Gothenburg, Sweden. The FEBS Journal, Vol.277, Suppl. 1, A4.10, 2010; 79.      

19Zvejniece L.; Svalbe B.; Dambrova M. Antihypoxic action of an inhibitor of L-carnitine biosynthesis. Meeting of the COST Action TD0901 Oxygen in Health and Disease; June 15-18: Smolenice Castle, Slovakia, 2010; 65.      

20Kuka J.; Vilskersts R.; Vavers E.; Liepins E.; Dambrova M. Effects of regulation of L-carnitine concentration in experimental heart infarction model. Final Programme and Abstract Book, Frontiers in Cardiovascular Biology; First Congress of the European Society of Cardiology Council on Basic Cardiovascular Science; Berlin, 16-19 July: Cardiovascular Res., Vol.87, Suppl.1. Oxford Journals, 2010; 509.      

Show per page